Feb 20, 2024 Leave a message

Prisys Biotech 2024 Q1 Newsletter - your reliable NonHuman Primate study specialist

1. Integration of NHP Supply-chain

Integration of NHP Supply-chain

Youlink Biotech Co., a Prisys subsidiary firm specialized in experimental Nonhuman Primate (NHP) breeding, started operation in early 2023, and is by far the southern-most NHP center in China.

The original habitat environment provides cost-effective and high-welfare NHP breeding.

The colony supports long-term experimental plans for collaborators of Prisys.

 

2. GLP-studies in NHP and other species

GLP-studies in NHP and other species

Business integration with a local leading institute, experienced and qualiied in both USFDA/OECD submission for INDs.

 

3. Strategies for organ-targeted drug delivery

Strategies for organ-targeted drug delivery

Specialized technologies in large animals, enabling multi-organ administration to enhance PD, efficacy, and transformation.

 

4. Breakthrough on CNS research in NHP

Breakthrough on CNS research in NHP

Advanced technologies combining the use of AI-algorithm, high-speed photography, brain mapping & navigation etc., drive neuro-disorder therapy R&Ds to the next level.

 

Contact us

Prisys Biotechnologies Co., Ltd.

Website: www.prisysbiotech.com

Email: bd@prisysbiotech.com

Address: 6055 Jinhai Highway, Building 7, Fengxian, Shanghai, 201499, China

https://www.prisysbiotech.com/uploads/39406/files/Prisys-Q1-Newsletter-.pdf

 
 
 
 
 
 
 
 
 
 

Send Inquiry

Home

Phone

E-mail

Inquiry